Background-Raised triglyceride-rich lipoproteins significantly increase the
risk for cardiovascular disease. Variation in the activity of the enzyme l
ipoprotein lipase (LPL), which is crucial in the removal of these lipoprote
ins, may therefore modulate this risk.
Methods and Results-Postheparin levels of LPL activity and mass were measur
ed in a large cohort of male coronary artery disease patients participating
in the Regression Growth Evaluation Statin Study (REGRESS), a lipid-loweri
ng regression trial. In addition, the relationships between LPL activity an
d mass and severity of angina pectoris according to the NYHA classification
and silent ischemia on 24-hour ambulatory ECG monitoring were assessed. Pa
tients in different LPL activity quartiles and mass had different severitie
s of angina; a total of 47% of patients in the lowest LPL quartile reported
class III or IV angina. In contrast, only 29% in the highest activity quar
tile (P=0.002) had severe angina. These parameters were supported by ambula
tory ECG results, for which the total ischemic burden in the lowest LPL act
ivity quartile was 36.5+/-104.1 mmxmin compared with 14.8+/-38.8 mmxmin in
the highest quartile of LPL activity (P=0.001), LPL activity levels were st
rongly correlated with LPL mass (r=0.70, P<0.0001). A significant associati
on between the LPL protein mass and NYHA class (P=0.012) was also demonstra
ted.
Conclusions-We have demonstrated a significant relationship between LPL mas
s and activity and severity of ischemia as defined by angina class and ambu
latory EGG. These results suggest that LPL influences risk for coronary art
ery disease by both catalytic and noncatalytic mechanisms.